|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bruix J, Gores GJ and Mazzaferro V:
Hepatocellular carcinoma: Clinical frontiers and perspectives. Gut.
63:844–855. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang C, Jin G, Jin H, Wang N, Luo Q, Zhang
Y, Gao D, Jiang K, Gu D, Shen Q, et al: Clusterin facilitates
metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular
carcinoma. Oncotarget. 6:2903–2916. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yusup G, Akutsu Y, Mutallip M, Qin W, Hu
X, Komatsu-Akimoto A, Hoshino I, Hanari N, Mori M, Akanuma N, et
al: A COX-2 inhibitor enhances the antitumor effects of
chemotherapy and radiotherapy for esophageal squamous cell
carcinoma. Int J Oncol. 44:1146–1152. 2014.PubMed/NCBI
|
|
6
|
Zheng CY, Xiao W, Zhu MX, Pan XJ, Yang ZH
and Zhou SY: Inhibition of cyclooxygenase-2 by tetramethylpyrazine
and its effects on A549 cell invasion and metastasis. Int J Oncol.
40:2029–2037. 2012.PubMed/NCBI
|
|
7
|
Qian M, Qian D, Jing H, Li Y, Ma C and
Zhou Y: Combined cetuximab and celecoxib treatment exhibits a
synergistic anticancer effect on human oral squamous cell carcinoma
in vitro and in vivo. Oncol Rep. 32:1681–1688. 2014.PubMed/NCBI
|
|
8
|
Chen Z, Liu M, Liu X, Huang S, Li L, Song
B, Li H, Ren Q, Hu Z, Zhou Y, et al: COX-2 regulates E-cadherin
expression through the NF-κB/Snail signaling pathway in gastric
cancer. Int J Mol Med. 32:93–100. 2013.PubMed/NCBI
|
|
9
|
Honjo S, Kase S, Osaki M, Ardyanto TD,
Kaibara N and Ito H: COX-2 correlates with F-box protein, Skp2
expression and prognosis in human gastric carcinoma. Int J Oncol.
26:353–360. 2005.PubMed/NCBI
|
|
10
|
Chen JY, Li CF, Kuo CC, Tsai KK, Hou MF
and Hung WC: Cancer/stroma interplay via cyclooxygenase-2 and
indoleamine 2,3-dioxygenase promotes breast cancer progression.
Breast Cancer Res. 16:4102014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu M, Li CM, Chen ZF, Ji R, Guo QH, Li Q,
Zhang HL and Zhou YN: Celecoxib regulates apoptosis and autophagy
via the PI3K/Akt signaling pathway in SGC-7901 gastric cancer
cells. Int J Mol Med. 33:1451–1458. 2014.PubMed/NCBI
|
|
12
|
Zhang H, Li Z and Wang K: Combining
sorafenib with celecoxib synergistically inhibits tumor growth of
non-small cell lung cancer cells in vitro and in vivo. Oncol Rep.
31:1954–1960. 2014.PubMed/NCBI
|
|
13
|
Xia Q, Hu Q, Wang H, Yang H, Gao F, Ren H,
Chen D, Fu C, Zheng L, Zhen X, et al: Induction of COX-2-PGE2
synthesis by activation of the MAPK/ERK pathway contributes to
neuronal death triggered by TDP-43-depleted microglia. Cell Death
Dis. 6:e17022015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dong X, Li R, Xiu P, Dong X, Xu Z, Zhai B,
Liu F, Jiang H, Sun X, Li J, et al: Meloxicam executes its
antitumor effects against hepatocellular carcinoma in
COX-2-dependent and -independent pathways. PLoS One. 9:e928642014.
View Article : Google Scholar
|
|
15
|
Prasad R and Katiyar SK: Ultraviolet
radiation-induced inflammation activates β-catenin signaling in
mouse skin and skin tumors. Int J Oncol. 44:1199–1206.
2014.PubMed/NCBI
|
|
16
|
Tu B, Ma TT, Peng XQ, Wang Q, Yang H and
Huang XL: Targeting of COX-2 expression by recombinant adenovirus
shRNA attenuates the malignant biological behavior of breast cancer
cells. Asian Pac J Cancer Prev. 15:8829–8836. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jansen SR, Holman R, Hedemann I, Frankes
E, Elzinga CR, Timens W, Gosens R, de Bont ES and Schmidt M:
Prostaglandin E2 promotes MYCN non-amplified neuroblastoma cell
survival via β-catenin stabilization. J Cell Mol Med. 19:210–226.
2015. View Article : Google Scholar :
|
|
18
|
Shafie NH, Mohd Esa N, Ithnin H, Md Akim
A, Saad N and Pandurangan AK: Preventive inositol hexaphosphate
extracted from rice bran inhibits colorectal cancer through
involvement of Wnt/β-catenin and COX-2 pathways. Biomed Res Int.
2013:6810272013. View Article : Google Scholar
|
|
19
|
Gavert N and Ben-Ze'ev A: beta-Catenin
signaling in biological control and cancer. J Cell Biochem.
102:820–828. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Klaus A and Birchmeier W: Wnt signalling
and its impact on development and cancer. Nat Rev Cancer.
8:387–398. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang S, Zhu L, Tang H, Zhang M, Chen Z,
Fei J, Han B and Zou GM: Ape1 regulates WNT/β-catenin signaling
through its redox functional domain in pancreatic cancer cells. Int
J Oncol. 47:610–620. 2015.PubMed/NCBI
|
|
22
|
Du M, Shi F, Zhang H, Xia S, Zhang M, Ma
J, Bai X, Zhang L, Wang Y, Cheng S, et al: Prostaglandin E2
promotes human cholangiocarcinoma cell proliferation, migration and
invasion through the upregulation of β-catenin expression via EP3–4
receptor. Oncol Rep. 34:715–726. 2015.PubMed/NCBI
|
|
23
|
Qiu X, Cheng JC, Chang HM and Leung PC:
COX2 and PGE2 mediate EGF-induced E-cadherin-independent human
ovarian cancer cell invasion. Endocr Relat Cancer. 21:533–543.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang S, Da L, Yang X, Feng D, Yin R, Li
M, Zhang Z, Jiang F and Xu L: Celecoxib potentially inhibits
metastasis of lung cancer promoted by surgery in mice, via
suppression of the PGE2-modulated β-catenin pathway. Toxicol Lett.
225:201–207. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhong J, Xiu P, Dong X, Wang F, Wei H,
Wang X, Xu Z, Liu F, Li T, Wang Y, et al: Meloxicam combined with
sorafenib synergistically inhibits tumor growth of human
hepatocellular carcinoma cells via ER stress-related apoptosis.
Oncol Rep. 34:2142–2150. 2015.PubMed/NCBI
|
|
26
|
Zhong J, Dong X, Xiu P, Wang F, Liu J, Wei
H, Xu Z, Liu F, Li T and Li J: Blocking autophagy enhances
meloxicam lethality to hepatocellular carcinoma by promotion of
endoplasmic reticulum stress. Cell Prolif. 48:691–704. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang F, Dong X, Xiu P, Zhong J, Wei H, Xu
Z, Li T, Liu F, Sun X and Li J: T7 peptide inhibits angiogenesis
via downregulation of angiopoietin-2 and autophagy. Oncol Rep.
33:675–684. 2015.
|
|
28
|
Wang L, Wang Z, Li J, Zhang W, Ren F and
Yue W: NFATc1 activation promotes the invasion of U251 human
glioblastoma multiforme cells through COX-2. Int J Mol Med.
35:1333–1340. 2015.PubMed/NCBI
|
|
29
|
Park SY, Jin ML, Kim YH, Lee SJ and Park
G: Sanguinarine inhibits invasiveness and the MMP-9 and COX-2
expression in TPA-induced breast cancer cells by inducing HO-1
expression. Oncol Rep. 31:497–504. 2014.
|
|
30
|
Liu X, Ji Q, Ye N, Sui H, Zhou L, Zhu H,
Fan Z, Cai J and Li Q: Berberine inhibits invasion and metastasis
of colorectal cancer cells via COX-2/PGE2 mediated JAK2/STAT3
signaling pathway. PLoS One. 10:e01234782015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin X, Li HR, Lin XF, Yu ME, Tu XW, Hua
ZD, Lin M, Xu NL, Han LL and Chen YS: Silencing of Livin inhibits
tumorigenesis and metastasis via VEGF and MMPs pathway in lung
cancer. Int J Oncol. 47:657–667. 2015.PubMed/NCBI
|
|
32
|
Chou YC, Chang MY, Wang MJ, Yu FS, Liu HC,
Harnod T, Hung CH, Lee HT and Chung JG: PEITC inhibits human brain
glioblastoma GBM 8401 cell migration and invasion through the
inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and
-9 gene expression. Oncol Rep. 34:2489–2496. 2015.PubMed/NCBI
|
|
33
|
Campbell K and Casanova J: A role for
E-cadherin in ensuring cohesive migration of a heterogeneous
population of non-epithelial cells. Nat Commun. 6:79982015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fang Y, Liang X, Jiang W, Li J, Xu J and
Cai X: Cyclin b1 suppresses colorectal cancer invasion and
metastasis by regulating e-cadherin. PLoS One. 10:e01268752015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Singh T and Katiyar SK: Honokiol inhibits
non-small cell lung cancer cell migration by targeting
PGE2-mediated activation of β-catenin signaling. PLoS
One. 8:e607492013. View Article : Google Scholar
|
|
36
|
Yun SP, Ryu JM, Park JH, Kim MO, Lee JH
and Han HJ: Prostaglandin E2 maintains mouse ESC
undifferentiated state through regulation of connexin31, connexin43
and connexin45 expression: involvement of glycogen synthase kinase
3β/β-catenin. Biol Cell. 104:378–396. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ho MY, Hung SW, Liang CM and Liang SM:
Recombinant viral capsid protein VP1 suppresses lung cancer
metastasis by inhibiting COX-2/PGE2 and MIG-7. Oncotarget.
5:3931–3943. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lee CS, Cho HJ, Jeong YJ, Shin JM, Park
KK, Park YY, Bae YS, Chung IK, Kim M, Kim CH, et al:
Isothiocyanates inhibit the invasion and migration of C6 glioma
cells by blocking FAK/JNK-mediated MMP-9 expression. Oncol Rep.
34:2901–2908. 2015.PubMed/NCBI
|
|
39
|
Chen F, Deng J, Liu X, Li W and Zheng J:
HCRP-1 regulates cell migration and invasion via EGFR-ERK mediated
up-regulation of MMP-2 with prognostic significance in human renal
cell carcinoma. Sci Rep. 5:134702015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Peng X, Zhou Y, Tian H, Yang G, Li C, Geng
Y, Wu S and Wu W: Sulforaphane inhibits invasion by phosphorylating
ERK1/2 to regulate E-cadherin and CD44v6 in human prostate cancer
DU145 cells. Oncol Rep. 34:1565–1572. 2015.PubMed/NCBI
|
|
41
|
Tao H, Guo L, Chen L, et al: MSX1 inhibits
cell migration and invasion through regulating the Wnt/beta-catenin
pathway in glioblastoma. Tumour Biol. Aug 15–2015.Epub ahead of
print.
|
|
42
|
Yang C, Li C, Li M, Tong X, Hu X, Yang X,
Yan X, He L and Wan C: CYP2S1 depletion enhances colorectal cell
proliferation is associated with PGE2-mediated activation of
β-catenin signaling. Exp Cell Res. 331:377–386. 2015. View Article : Google Scholar : PubMed/NCBI
|
